
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5844626
[patent_doc_number] => 20060122244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Use of compounds'
[patent_app_type] => utility
[patent_app_number] => 11/339188
[patent_app_country] => US
[patent_app_date] => 2006-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5872
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11339188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/339188 | Use of compounds | Jan 24, 2006 | Abandoned |
Array
(
[id] => 8374964
[patent_doc_number] => 08257755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/795638
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 7517
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11795638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795638 | Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same | Jan 19, 2006 | Issued |
Array
(
[id] => 5889872
[patent_doc_number] => 20060276416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Methods and compositions for treating flushing and drug induced weight gain'
[patent_app_type] => utility
[patent_app_number] => 11/336258
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 74949
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276416.pdf
[firstpage_image] =>[orig_patent_app_number] => 11336258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/336258 | Methods and compositions for treating flushing and drug induced weight gain | Jan 19, 2006 | Abandoned |
Array
(
[id] => 5349962
[patent_doc_number] => 20090005323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Cathepsin K Inhibitors and Obesity'
[patent_app_type] => utility
[patent_app_number] => 11/795447
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10656
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795447
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795447 | Cathepsin K Inhibitors and Obesity | Jan 16, 2006 | Abandoned |
Array
(
[id] => 159391
[patent_doc_number] => 07674790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-09
[patent_title] => 'Processes of making and using pharmaceutical formulations of antineoplastic agents'
[patent_app_type] => utility
[patent_app_number] => 11/332721
[patent_app_country] => US
[patent_app_date] => 2006-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5671
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/674/07674790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11332721
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/332721 | Processes of making and using pharmaceutical formulations of antineoplastic agents | Jan 12, 2006 | Issued |
Array
(
[id] => 5673024
[patent_doc_number] => 20060178379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods of treating patients suffering from movement disorders'
[patent_app_type] => utility
[patent_app_number] => 11/326414
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19349
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178379.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326414
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326414 | Administering adenosine A2A receptor antagonist to reduce or suppress side effects of parkinson's disease therapy | Jan 5, 2006 | Issued |
Array
(
[id] => 5632357
[patent_doc_number] => 20060148827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Methods of treating patients suffering from movement disorders'
[patent_app_type] => utility
[patent_app_number] => 11/326516
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20472
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148827.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326516
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326516 | Methods of treating patients suffering from movement disorders | Jan 5, 2006 | Issued |
Array
(
[id] => 4553165
[patent_doc_number] => 07820656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Pharmaceutical composition comprising N-aryl N′ morpholino/piperidino thiocarbamide derivatives for treating type II diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/315696
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4923
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820656.pdf
[firstpage_image] =>[orig_patent_app_number] => 11315696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/315696 | Pharmaceutical composition comprising N-aryl N′ morpholino/piperidino thiocarbamide derivatives for treating type II diabetes | Dec 21, 2005 | Issued |
Array
(
[id] => 5527791
[patent_doc_number] => 20090197868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => '5ht2c receptor modulator compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/793941
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30426
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793941
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793941 | 5ht2C receptor modulator compositions | Dec 20, 2005 | Issued |
Array
(
[id] => 5011509
[patent_doc_number] => 20070281988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Combination Therapy for Vascular Complications Associated with Hyperglycemia'
[patent_app_type] => utility
[patent_app_number] => 11/720087
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3768
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281988.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720087
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720087 | Combination Therapy for Vascular Complications Associated with Hyperglycemia | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5865067
[patent_doc_number] => 20060099197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Probiotic, lactic acid-producing bacteria and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/305507
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19468
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11305507
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/305507 | Probiotic, lactic acid-producing bacteria and uses thereof | Dec 15, 2005 | Issued |
Array
(
[id] => 5866145
[patent_doc_number] => 20060100276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Method of treating neutrophil-related diseases with topical anesthetics'
[patent_app_type] => utility
[patent_app_number] => 11/300846
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8147
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100276.pdf
[firstpage_image] =>[orig_patent_app_number] => 11300846
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/300846 | Method of treating neutrophil-related diseases with topical anesthetics | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5016719
[patent_doc_number] => 20070259928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Medicinal Composition for Treating Diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/792879
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4398
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259928.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792879 | Medicinal Composition for Treating Diabetes | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5304093
[patent_doc_number] => 20090298745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => ' Treatment of Diabetes with Glycogen Phosphorylase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/792186
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10925
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298745.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792186
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792186 | Treatment of Diabetes with Glycogen Phosphorylase Inhibitors | Dec 1, 2005 | Abandoned |
Array
(
[id] => 4903633
[patent_doc_number] => 20080113046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients'
[patent_app_type] => utility
[patent_app_number] => 11/792060
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2387
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113046.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792060
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792060 | Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients | Dec 1, 2005 | Abandoned |
Array
(
[id] => 5716202
[patent_doc_number] => 20060079565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Amino acid composition and supplementary liquid containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/289383
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5075
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11289383
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/289383 | Amino acid composition and supplementary liquid containing the same | Nov 29, 2005 | Issued |
Array
(
[id] => 5716117
[patent_doc_number] => 20060079480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Novel antifolate combination therapies'
[patent_app_type] => utility
[patent_app_number] => 11/288807
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5557
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079480.pdf
[firstpage_image] =>[orig_patent_app_number] => 11288807
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/288807 | Novel antifolate combination therapies | Nov 28, 2005 | Abandoned |
Array
(
[id] => 142146
[patent_doc_number] => 07687544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-30
[patent_title] => 'Method of using catalpic acid to treat type 2 diabetes and associated disorders'
[patent_app_type] => utility
[patent_app_number] => 11/287588
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8021
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/687/07687544.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287588
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287588 | Method of using catalpic acid to treat type 2 diabetes and associated disorders | Nov 27, 2005 | Issued |
Array
(
[id] => 5655290
[patent_doc_number] => 20060141025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Methods and compositions for delivery of catecholic butanes for treatment of tumors'
[patent_app_type] => utility
[patent_app_number] => 11/284111
[patent_app_country] => US
[patent_app_date] => 2005-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25558
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141025.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284111
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284111 | Methods for delivery of catecholic butanes for treatment of tumors | Nov 20, 2005 | Issued |
Array
(
[id] => 4461013
[patent_doc_number] => 07879865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Treatment of cancer of the brain using histone deacetylase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/282420
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1989
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282420
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282420 | Treatment of cancer of the brain using histone deacetylase inhibitors | Nov 17, 2005 | Issued |